CD4 and cancer: Although we do not know the mechanistic basis of our observation related to the requirement for CD4+ T cell help for the generation of therapeutic primary immune responses against cancer, it is tempting to speculate that CD4+ T cells may facilitate vaccine efficacy by several means.